Skip to main content
TipRanks
Go Ultimate75% OFF

Hans-Peter Rudolf Insider Profile

4 Followers

Hans-Peter Rudolf, Chief Financial Officer at Shield Therapeutics, holds ― shares in Shield Therapeutics (Ticker: GB:STX). Most recently, Hans-Peter Rudolf Bought 1,359,434 shares of Shield Therapeutics on Dec 13, 2022 for an estimated value of 81.57K .

Hans-Peter Rudolf's Trading History

STX
Shield Therapeutics
Dec 13, 2022Chief Financial OfficerInformative Buy81.57K―
GB:STX
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Dec 13, 2022Informative Buy£81.57K1,359,434£6.00――

You May Also Like

Hans-Peter Rudolf insider profile FAQ

What stocks does Hans-Peter Rudolf hold?
Hans-Peter Rudolf holds: GB:STX stocks.
What was Hans-Peter Rudolf’s latest transaction?
Hans-Peter Rudolf’s latest transaction was an Informative Buy of 81.57K .
What is Hans-Peter Rudolf's role in Shield Therapeutics?
Hans-Peter Rudolf's role in Shield Therapeutics is Chief Financial Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.